Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 14/20 | 0.61 |
| ▸ | TLR7 | Q9NYK1 | 10/20 | 0.61 |
| ▸ | DHFR | P00374 | 1/20 | 0.48 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.43 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
| ▸ | PI4KA | P42356 | 1/20 | 0.43 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5146429 | 0.83 | TLR8 (0.61) | TLR8TLR7 | |
| SCHEMBL3981001 | 0.82 | TLR8 (0.60) | TLR8TLR7LIMK1 | |
| SCHEMBL5531698 | 0.81 | DHFR (0.44) | TLR8TLR7DHFRLIMK1PIK3CD | |
| SCHEMBL5146571 | 0.81 | TLR8 (0.57) | TLR8TLR7DHFRLIMK1 | |
| SCHEMBL2401205 | 0.80 | TLR8 (0.54) | TLR8TLR7 | |
| SCHEMBL3988438 | 0.78 | TLR8 (0.54) | TLR8TLR7DHFRLIMK1 | |
| SCHEMBL5144714 | 0.78 | TLR8 (0.54) | TLR8TLR7DHFRLIMK1CYP11B1 | |
| SCHEMBL1527827 | 0.78 | TLR8 (0.70) | TLR8TLR7 | |
| SCHEMBL5144935 | 0.77 | TLR8 (0.53) | TLR8TLR7DHFR | |
| SCHEMBL3503556 | 0.77 | TLR8 (0.56) | TLR8TLR7DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1804583-A4 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES CO (US) | 2009-05-20 | — | — | EP | claimed |
| US-20070243215-A1 | Adjuvant for Dna Vaccines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-10-18 | — | — | US | claimed |
| EP-1804583-A2 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006042254-A2 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-04-20 | — | — | WO | claimed |
| EP-1804583-A4 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES CO (US) | 2009-05-20 | — | — | EP | disclosed |
| EP-1680080-A4 | NEUTROPHIL ACTIVATION BY IMMUNE RESPONSE MODIFIER COMPOUNDS | 3M INNOVATIVE PROPERTIES CO (US) | 2007-10-31 | — | — | EP | disclosed |
| US-20070243215-A1 | Adjuvant for Dna Vaccines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-10-18 | — | — | US | disclosed |
| EP-1804583-A2 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1680080-A2 | NEUTROPHIL ACTIVATION BY IMMUNE RESPONSE MODIFIER COMPOUNDS | 3M Innovative Properties Company (US) | 2006-07-19 | — | — | EP | disclosed |
| WO-2006042254-A2 | ADJUVANT FOR DNA VACCINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-04-20 | — | — | WO | disclosed |
| WO-2005041891-A2 | NEUTROPHIL ACTIVATION BY IMMUNE RESPONSE MODIFIER COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050096259-A1 | Neutrophil activation by immune response modifier compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2005-05-05 | — | — | US | disclosed |